Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 5, 2006Tropical Medicine & International HealthOpen Access

An open label randomized comparison of mefloquine–artesunate as separate tablets vs. a new co‐formulated combination for the treatment of uncomplicated multidrug‐resistant falciparum malaria in Thailand

View Full Paper
Ask AI
Bookmark
Share

Authors

EAElizabeth A. AshleyMahosot HospitalKLKhin Maung LwinMahidol UniversityRMRose McGreadyMahidol University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ashley et al. (2006) studied this question.

synapsesocial.com/papers/6aacf9e981eaed9638bcbea1https://doi.org/10.1111/j.1365-3156.2006.01724.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria1995 · 101 citations
  2. 2Manson’s tropical diseases2004 · 246 citations
  3. 3Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.1999 · 144 citations
  4. 4Randomized, Controlled Dose‐Optimization Studies of Dihydroartemisinin‐Piperaquine for the Treatment of Uncomplicated Multidrug‐Resistant Falciparum Malaria in Thailand2004 · 113 citations
  5. 5A Randomized, Controlled Study of a Simple, Once-Daily Regimen of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated, Multidrug-Resistant Falciparum Malaria2005 · 128 citations